Our analysis revealed that SLC16A1 expression was significantly higher in various cancers, including ACC, CESE, CESC, COAD, DLBC, ESCA, GBM, HNSC, KIRC, KICH, LGG, TGCT, SKCM, LIHC, LUSC, OV, PAAD, READ, STAD, and THYM, compared to their respective normal tissues. This evidence concerns the gene SLC16A1 and adrenal cortex carcinoma.